Potentials of Antitussive Traditional Persian Functional Foods for COVID-19 Therapy†

Ghazaleh Mosleh1, Parmis Badr1,2, Meysam Zaeri3

  • 1Phytopharmaceutical Technology and Traditional Medicine Incubator, Shiraz University of Medical Sciences, Shiraz, Iran.

Insights

Traditional Persian medicine offers functional foods as safe, cost-effective options for managing COVID-19 symptoms and respiratory discomfort. These natural remedies provide antiviral, anti-inflammatory, and antitussive effects, supporting recovery and prevention.

Area of Science:

  • Integrative Medicine
  • Pharmacology
  • Public Health

Background:

  • Coronavirus disease 2019 (COVID-19) is a global pandemic necessitating novel therapeutic strategies beyond FDA-approved antivirals.
  • Functional foods (FFs) present potential co-therapeutic and protective roles in managing COVID-19 infection.
  • Traditional Persian medicine (TPM) offers a historical and safe approach to managing health conditions, including respiratory ailments.

Purpose of the Study:

  • To investigate the potential of Traditional Persian medicine (TPM) functional foods (FFs) as antitussive agents for COVID-19.
  • To identify specific TPM formulations and their ingredients with relevant pharmacological activities against COVID-19 symptoms.

Main Methods:

  • Searched the "Qarabadin-e-Salehi" pharmacopoeia for antitussive FFs using keywords "Soaal" and "Sorfeh."
  • Conducted a literature review of MEDLINE, PubMed Central, Google Scholar, and Science Direct up to March 2021.
  • Utilized search terms including "cough, antitussive, antioxidant, anti-inflammation, antiviral, COVID-19, mucoactive, mucolytic, expectorant, and mucoregulatory."

Main Results:

  • Identified twelve TPM FFs (Laooqs, Morabbas, Saviq, soup, syrup) comprising 2-7 ingredients.
  • These FFs possess pharmacological mechanisms including antiviral, anti-inflammatory, antioxidant, antihistamine, bronchodilator, immunomodulatory, and mucoactive effects.
  • Natural compounds in these formulations demonstrated central and peripheral antitussive activities relevant to COVID-19.

Conclusions:

  • TPM FFs are cost-effective, accessible, and safe options for COVID-19 treatment and prevention.
  • These FFs may offer psychological benefits alongside pharmacological and nutritional advantages.
  • TPM FFs can effectively manage persistent respiratory discomfort following COVID-19 recovery.

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
591
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
424
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
730
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
219
Upper Respiratory Drugs: Decongestants01:27

Upper Respiratory Drugs: Decongestants

Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
476
Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
913